Valerio Therapeutics Société anonyme (EPA:ALVIO)
France · Delayed Price · Currency is EUR 0.7640
+0.0230 (3.10%)
Aug 3, 2026, 1:49 PM CET
EPA:ALVIO Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 370 | 67 | 12 | 25 | 16 | 39 | |
Market Cap Growth | 2978.61% | 484.19% | -54.58% | 62.58% | -59.41% | -25.93% |
Enterprise Value | 377 | 88 | 21 | 22 | 4 | 25 |
Last Close Price | 0.74 | 0.14 | 0.07 | 0.17 | 0.14 | 0.42 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 47.52 | 47.52 | 47.52 | 47.52 | 47.52 |
PS Ratio | 143.84 | 26.22 | 6.44 | 14.12 | 10.84 | 9.48 |
PB Ratio | 178.27 | 32.50 | -1.40 | 1.72 | 0.70 | 1.17 |
P/TBV Ratio | - | - | - | - | 3.71 | 2.59 |
P/FCF Ratio | 710.35 | 129.48 | - | - | - | - |
P/OCF Ratio | 201.25 | 36.68 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 146.66 | 34.33 | 11.58 | 12.33 | 2.50 | 6.06 |
EV/EBITDA Ratio | - | 25.60 | - | - | - | - |
EV/FCF Ratio | 724.28 | 169.51 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 4.00 | 4.00 | -2.00 | 0.74 | 0.46 | 0.30 |
Debt / EBITDA Ratio | 2.14 | 2.14 | - | - | - | - |
Debt / FCF Ratio | 15.96 | 15.96 | - | - | - | - |
Net Debt / Equity Ratio | 3.50 | 3.50 | -1.86 | 0.28 | -0.20 | -0.24 |
Net Debt / EBITDA Ratio | 2.10 | 2.10 | -3.95 | -0.22 | 0.26 | 1.44 |
Net Debt / FCF Ratio | 13.94 | 13.94 | -1.20 | -0.24 | 0.45 | 0.91 |
Asset Turnover | 0.16 | 0.16 | 0.07 | 0.05 | 0.03 | 0.08 |
Quick Ratio | 0.73 | 0.73 | 0.25 | 1.05 | 2.78 | 4.06 |
Current Ratio | 0.76 | 0.76 | 0.25 | 1.17 | 2.88 | 4.27 |
Return on Equity (ROE) | - | - | -731.83% | -109.75% | -70.86% | -19.16% |
Return on Assets (ROA) | -2.07% | -2.07% | -38.74% | -30.39% | -22.25% | -7.01% |
Return on Invested Capital (ROIC) | -5.89% | -12.32% | -177.49% | -103.53% | -79.95% | -24.40% |
Return on Capital Employed (ROCE) | -6.20% | -6.20% | 4041.70% | -78.90% | -47.60% | -12.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.32% | -7.26% | -207.23% | -80.02% | -125.10% | -15.41% |
FCF Yield | 0.14% | 0.77% | -110.66% | -69.13% | -63.51% | -22.61% |
Buyback Yield / Dilution | -78.10% | -78.10% | -13.81% | -27.86% | -19.88% | -17.03% |